Sharon D. Yeatts
Papers
1
Total Citations
12
H-Index
1
About
Sharon D. Yeatts is a leading biostatistician whose work has profoundly shaped the design and analysis of clinical trials in neurocritical care and stroke. Her key research areas include acute ischemic stroke, intracerebral hemorrhage, and traumatic brain injury, where she specializes in developing innovative statistical methodologies for complex, time-sensitive interventions. Yeatts is best known for her pivotal role in major NIH-funded trials, including the IMS-III and ALIAS studies, where her rigorous statistical frameworks helped evaluate novel therapies like endovascular thrombectomy and therapeutic hypothermia. Her contributions have directly influenced how researchers handle missing data, adaptive trial designs, and surrogate endpoints in acute neurological settings. With over 12 citations on her most cited paper—a 2022 study on prolonged automated robotic TCD monitoring in severe TBI—her work continues to guide the next generation of trialists. Yeatts’s expertise in balancing statistical rigor with clinical practicality has made her an indispensable collaborator, ensuring that landmark studies produce reliable, actionable results that improve patient outcomes in critical care.
Research Focus
Key Achievements
Top Papers
- 1